Leuk. Res.

PLENARY SESSION 1: MOLECULAR PATHOGENESIS OF MDS

Moura P, Branca R, Kaminskiy Y, ..., Lehtiö J, Hellstrom-Lindberg E

Leuk. Res. 156 (-) 107747 [2025-09-00; online 2025-09-00]

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROW AND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS

Lindholm C, Tobiasson M, Pandzic T, ..., Dybedal I, Hellstrom-Lindberg E

Leuk. Res. 128 (-) 107227 [2023-05-00; online 2023-05-00]

Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli.

Söderlund S, Christiansson L, Persson I, ..., Olsson-Strömberg U, Loskog A

Leuk. Res. 50 (-) 95-103 [2016-11-00; online 2016-09-27]

Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays.

Pauly F, Smedby KE, Jerkeman M, ..., Borrebaeck CA, Wingren C

Leuk. Res. 38 (6) 682-690 [2014-06-00; online 2014-03-22]